CRISPR Market: By Product Type (Vector-based Cas, DNA-free Cas), By Application (Functional Genomics, Knockdown/activation, Genome Engineering, Disease models, Other Applications), By Distribution Channel (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Others), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

CRISPR Market size is valued at USD 1,087.2 million in 2022 and is expected to reach USD 5,068.9 million by 2029, at a CAGR of 24.6% during the forecast period 2023-2029. CRISPR is an acronym for Clustered Regularly Interspaced Short Palindromic Repeat. CRISPR is also called as CRISPR/Cas9. The scientific world is attracted by this revolutionary technology. CRISPR technology is a simple yet powerful tool that is used for editing genomes. This technology is used to alter the DNA sequence and modify gene function. Its major application includes correcting genetic defects, treating, and preventing the spread of diseases and is also used improving crops. The technological advancements are the key factors attributed for the growth of the CRISPR market. Increase in the prevalence of genetic and growing drug discovery activities are expected to boost the market revenue growth. The growing demand for synthetic genes and increase in the R&D expenditure on biotechnology and raising government expenditure on genetic research is enriching the growth of the CRISPR market. However, complications such as gene editing of germ line cells are hindering the growth of the market. Since the changes made in germ line cells are transferred to the next generations. The gene editing of germ line cells also has ethical issues and is illegal in most of the countries such as the UK. Limited awareness is another factor hindering the growth of the CRISPR market.

Crispr Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

24.6%

Largest Market

North-America

Fastest Growing Market

Asia Pacific
CRISPR Market Dynamics

During the projected period, technological developments in CRISPR and the launch of anti-CRISPR proteins are expected to drive the market. The market is predicted to develop due to the growing acceptance of CRISPR technology in pharmaceuticals, epigenetics, plant genome editing, human germline editing, and other disciplines of biotechnology. CRISPR-Cas systems also have uses in culture immunisation, self-targeted cell death, bacterial strain typing, and altering metabolic pathways to increase biochemical synthesis, all of which contribute to the global market's expansion.

Key Features of the Reports

  • The crispr market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Crispr Market Segmentation

By Product Type
  • Vector-based Cas
  • DNA-free Cas
By Application
  • Functional Genomics
  • Knockdown/activation
  • Genome Engineering
  • Disease models
  • Other Applications
By Distribution Channel
  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Others

Frequently Asked Questions

The CRISPR Market size was valued at USD 1,087.2 million in 2022

The crispr market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  1. Executive Summary
  2. Global CRISPR Market Introduction
    • Global CRISPR Market Taxonomy
    • Global CRISPR Market Definitions
      • Product Type
      • Application
      • End User
  1. Global CRISPR Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global CRISPR Market Dynamic Factors - Impact Analysis
    • Global CRISPR Market Competition Landscape
    • Epidemiology
  2. Global CRISPR Market Analysis,2018 - 2022 and Forecast, 2023 - 2029
    • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global CRISPR Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Vector-based Cas
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • DNA-free Cas
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global CRISPR Market Forecast, By Application, 2018 - 2022 and Forecast, 2023 - 2029
    • Functional Genomics
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Knockdown/activation
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Genome Engineering
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Disease models
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Other Applications
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global CRISPR Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Biotechnology & Pharmaceutical Companies
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Academic & Government Research Institutes
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global CRISPR Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global CRISPR Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Region, 2023 - 2029
  2. North America CRISPR Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Vector-based Cas
      • DNA-free Cas
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Functional Genomics
      • Knockdown/activation
      • Genome Engineering
      • Disease models
      • Other Applications
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Biotechnology & Pharmaceutical Companies
      • Academic & Government Research Institutes
      • Others
    • Country Analysis 2016 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America CRISPR Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2023 - 2029
    • North America CRISPR Market Dynamics Trends
  3. Europe CRISPR Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Vector-based Cas
      • DNA-free Cas
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Functional Genomics
      • Knockdown/activation
      • Genome Engineering
      • Disease models
      • Other Applications
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Biotechnology & Pharmaceutical Companies
      • Academic & Government Research Institutes
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe CRISPR Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2023 - 2029
    • Europe CRISPR Market Dynamics Trends
  4. Asia-Pacific CRISPR Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Vector-based Cas
      • DNA-free Cas
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Functional Genomics
      • Knockdown/activation
      • Genome Engineering
      • Disease models
      • Other Applications
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Biotechnology & Pharmaceutical Companies
      • Academic & Government Research Institutes
      • Others
    • Country Analysis2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific CRISPR Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2023 - 2029
    • Asia-Pacific CRISPR Market Dynamics Trends
  5. Latin America CRISPR Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Vector-based Cas
      • DNA-free Cas
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Functional Genomics
      • Knockdown/activation
      • Genome Engineering
      • Disease models
      • Other Applications
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Biotechnology & Pharmaceutical Companies
      • Academic & Government Research Institutes
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America CRISPR Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2023 - 2029
    • Latin America CRISPR Market Dynamics Trends
  6. Middle East and Africa CRISPR Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Vector-based Cas
      • DNA-free Cas
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Functional Genomics
      • Knockdown/activation
      • Genome Engineering
      • Disease models
      • Other Applications
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Biotechnology & Pharmaceutical Companies
      • Academic & Government Research Institutes
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA CRISPR Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2023 - 2029
    • MEA CRISPR Market Dynamics Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Transposagen Biopharmaceuticals (U.S)
      • Agilent Technologies, Inc. (U.S)
      • Merck KGaA (Germany)
      • Rockland Immunochemicals, Inc. (U.S)
      • Applied StemCell, Inc. (U.S)
      • Cellecta, Inc. (U.S)
      • GeneCopoeia, Inc. (U.S)
      • Horizon Discovery plc (UK)
      • Mirus Bio LLC (U.S)
      • New England Biolabs (U.S)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

  • Transposagen Biopharmaceuticals (U.S)
  • Agilent Technologies, Inc. (U.S)
  • Merck KGaA (Germany)
  • Rockland Immunochemicals, Inc. (U.S)
  • Applied StemCell, Inc. (U.S)
  • Cellecta, Inc. (U.S)
  • GeneCopoeia, Inc. (U.S)
  • Horizon Discovery plc (UK)
  • Mirus Bio LLC (U.S)
  • New England Biolabs (U.S)

Adjacent Markets